Clinical utility of noninvasive fetal trisomy (NIFTY) test--early experience
- PMID: 22471583
- PMCID: PMC3483059
- DOI: 10.3109/14767058.2012.678442
Clinical utility of noninvasive fetal trisomy (NIFTY) test--early experience
Abstract
Objective: To report the initial experience of noninvasive prenatal diagnosis of fetal Down syndrome (The NIFTY test) in a clinical setting.
Methods: The NIFTY test was offered as a screening test for fetal Down syndrome to pregnant women with a singleton pregnancy at 12 weeks of gestation or beyond. A satisfaction questionnaire was sent to the first 400 patients.
Results: During a 6-month period, 567 NIFTY tests were performed. Over 90% of those studied were ethnic Chinese, and the mean age of the women studied was 36 years. The test was performed at 12-13 weeks of gestation in 49.21%. The median reporting time was 9 days. The test was positive for trisomy 21 in eight cases, and for trisomy 18 in 1 case; all were confirmed by fetal karyotyping. There was no false-positive result. Of the questionnaires, 182 completed responses were received. Over 95% had complete or almost complete resolution of anxiety. Except for one, all were satisfied with the NIFTY test, and all indicated that they would recommend the test to their friends.
Conclusion: The NIFTY test was a highly specific test. Unnecessary invasive tests and associated fetal losses could be avoided in almost all women who have a normal fetus.
Similar articles
-
[Value of detection of cell-free fetal DNA in maternal plasma in the prenatal diagnosis of chromosomal abnormalities].Zhonghua Fu Chan Ke Za Zhi. 2012 Nov;47(11):808-12. Zhonghua Fu Chan Ke Za Zhi. 2012. PMID: 23302119 Chinese.
-
[Non-invasive fetal trisomy (NIFTY) test in prenatal diagnosis].Ginekol Pol. 2014 Apr;85(4):300-3. doi: 10.17772/gp/1727. Ginekol Pol. 2014. PMID: 24834709 Review. Polish.
-
Prenatal screening for fetal aneuploidy in singleton pregnancies.J Obstet Gynaecol Can. 2011 Jul;33(7):736-750. doi: 10.1016/S1701-2163(16)34961-1. J Obstet Gynaecol Can. 2011. PMID: 21749752
-
[Non-invasive prenatal diagnosis of the most common aneuploidies with cell-free fetal DNA in maternal serum--preliminary results].Ginekol Pol. 2014 Mar;85(3):208-13. doi: 10.17772/gp/1715. Ginekol Pol. 2014. PMID: 24783433 Polish.
-
Analysis of cell-free DNA in maternal blood in screening for fetal aneuploidies: updated meta-analysis.Ultrasound Obstet Gynecol. 2015 Mar;45(3):249-66. doi: 10.1002/uog.14791. Epub 2015 Feb 1. Ultrasound Obstet Gynecol. 2015. Update in: Ultrasound Obstet Gynecol. 2017 Sep;50(3):302-314. doi: 10.1002/uog.17484. PMID: 25639627 Updated. Review.
Cited by
-
Prenatal diagnosis of 4953 pregnant women with indications for genetic amniocentesis in Northeast China.Mol Cytogenet. 2019 Nov 6;12:45. doi: 10.1186/s13039-019-0457-x. eCollection 2019. Mol Cytogenet. 2019. PMID: 31709014 Free PMC article.
-
Effective Identification of Maternal Malignancies in Pregnancies Undergoing Noninvasive Prenatal Testing.Front Genet. 2022 Feb 10;13:802865. doi: 10.3389/fgene.2022.802865. eCollection 2022. Front Genet. 2022. PMID: 35265103 Free PMC article.
-
Genomics-based non-invasive prenatal testing for detection of fetal chromosomal aneuploidy in pregnant women.Cochrane Database Syst Rev. 2017 Nov 10;11(11):CD011767. doi: 10.1002/14651858.CD011767.pub2. Cochrane Database Syst Rev. 2017. PMID: 29125628 Free PMC article.
-
Analysis of 17,428 pregnant women undergoing non-invasive prenatal testing for fetal chromosome in Northeast China.Medicine (Baltimore). 2021 Feb 12;100(6):e24740. doi: 10.1097/MD.0000000000024740. Medicine (Baltimore). 2021. PMID: 33578623 Free PMC article.
-
Whole genome non-invasive prenatal testing in prenatal screening algorithm: clinical experience from 12,700 pregnancies.BMC Pregnancy Childbirth. 2022 Aug 9;22(1):633. doi: 10.1186/s12884-022-04966-8. BMC Pregnancy Childbirth. 2022. PMID: 35945516 Free PMC article.
References
-
- Nicolaides KH. Screening for fetal aneuploidies at 11 to 13 weeks. Prenat Diagn. 2011;31:7–15. - PubMed
-
- Leung TY, Chan LW, Law LW, Sahota DS, Fung TY, Leung TN, Lau TK. First trimester combined screening for Trisomy 21 in Hong Kong: outcome of the first 10,000 cases. J Matern Fetal Neonatal Med. 2009;22:300–304. - PubMed
-
- Susanne GO, Sissel S, Ulla W, Charlotta G, Sonja OL. Pregnant women's responses to information about an increased risk of carrying a baby with Down syndrome. Birth. 2006;33:64–73. - PubMed
-
- Lo YM, Corbetta N, Chamberlain PF, Rai V, Sargent IL, Redman CW, Wainscoat JS. Presence of fetal DNA in maternal plasma and serum. Lancet. 1997;350:485–487. - PubMed
-
- Ehrich M, Deciu C, Zwiefelhofer T, Tynan JA, Cagasan L, Tim R, Lu V, et al. Noninvasive detection of fetal trisomy 21 by sequencing of DNA in maternal blood: a study in a clinical setting. Am J Obstet Gynecol. 2011;204:205.e1–205.11. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical